...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Data Expected September 2019 for BETonMACE Phase 3 Cardiovascular Outcomes Trial for Apabetalone

Message: I wonder if this is common with Biotechs?

As did tada....suggesting that possibly DM had a laptop with a different slide show than what was put up on the website, one with the debt at $68.8.....Incidentally I never claimed I was "satisfied" with Clayton's response, merely that he answered and that I was dropping it.  

New Message
Please login to post a reply